Matthew Korenberg
Former President and Chief Operating Officer
COO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Ligand Pharmaceuticals Inc (LGND) | Former President and Chief Operating Officer | $385,545 | $13,165,669 |
| 2023 | Ligand Pharmaceuticals Inc (LGND) | Former President and Chief Operating Officer | $549,912 | $3,587,288 |
| 2022 | Ligand Pharmaceuticals Inc (LGND) | Former President and Chief Operating Officer | $519,858 | $6,542,545 |
| 2021 | Ligand Pharmaceuticals Inc (LGND) | President and Chief Operating Officer | $497,297 | $6,725,479 |
| 2020 | Ligand Pharmaceuticals Inc (LGND) | President and Chief Operating Officer | $482,833 | $3,111,136 |
| 2019 | Ligand Pharmaceuticals Inc (LGND) | Executive Vice President, Finance and Chief Financial Officer | $466,667 | $3,571,203 |
| 2018 | Ligand Pharmaceuticals Inc (LGND) | Executive Vice President, Finance and Chief Financial Officer | $428,438 | $2,668,630 |
| 2017 | Ligand Pharmaceuticals Inc (LGND) | Executive Vice President, Finance and Chief Financial Officer | $403,438 | $2,185,717 |
Executive changes
Earnings-call appearances
-
Ligand Pharmaceuticals Inc Q3 FY2022 Earnings Call2022-11-07
Ligand Pharmaceuticals Inc (LGND)
-
Ligand Pharmaceuticals Inc Q1 FY2021 Earnings Call2021-05-03
Ligand Pharmaceuticals Inc (LGND)